Rebalance Antiprotozoal label

Rebalance Antiprotozoal

Rebalance Antiprotozoal Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

For use in horses only. Do not use in horses intended for human consumption. Not for human use. Keep out of the reach of children.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

ReBalance Antiprotozoal Oral Suspension is indicated for the treatment of horses with equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona.

History

There is currently no drug history available for this drug.

Other Information

ReBalance Antiprotozoal Oral Suspension is supplied in 946.4 mL (1 quart) bottles.Each mL of ReBalance Antiprotozoal Oral Suspension contains 250 mg sulfadiazine (as the sodium salt) and 12.5 mg of pyrimethamine.

Rebalance Antiprotozoal Manufacturers

  • Prn Pharmacal
    Rebalance Antiprotozoal | Prn Pharmacal
    No Recall

    Rebalance Antiprotozoal | Prn Pharmacal

    Rebalance Antiprotozoal | Prn Pharmacal

    ReBalance Antiprotozoal Oral Suspension is to be administered at a dose of 20 mg/kg sulfadiazine and 1 mg/kg pyrimethamine daily or 4 mL of ReBalance Antiprotozoal Oral Suspension per 110 lb. (50 kg) of body weight once per day. The duration of treatment is dependent upon clinical response, but the usual treatment regimen ranges from 90 to 270 days.

    Administer orally by suitable dosing syringe at least one hour prior to feeding with hay or grain. Insert nozzle of syringe through the interdental space and deposit the dose on the back of the tongue by depressing the plunger. Shake well before use.